The suffering, the prolonged hospitalization and the great cost of osteomyelitis are obvious to those who have followed these patients through their hospital courses. There have been no studies that have brought out the marked economic loss entailed by this disease. A survey of the cases of osteomyelitis treated at the University of Virginia Hospital presents such a striking demonstration of this enormous economic burden that a presentation of the figures is thought to be worth
while. It is particularly worth while if it can be felt that earlier diagnosis and treatment can help decrease the expense to the patient and to the hospital. The moral of this report will then become obvious.
This study is limited to those cases of acute, pyogenic osteomyelitis of hematogenous origin, usually seen in children and most frequently caused by the staphylococcus. Other bone infections, including tuberculosis, traumatic osteitis, and osteitis originating in arthritis,
STONE CS. THE ECONOMIC BURDEN OF OSTEOMYELITIS. JAMA. 1933;100(17):1312–1314. doi:10.1001/jama.1933.02740170010002
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: